Do analysts rate BKYI or INTZ?

Intrusion has a consensus price target of $5.25, suggesting a potential upside of 683.58%. Given Intrusion's stronger consensus rating and higher probable upside, analysts plainly believe Intrusion is more favorable than BIO-key International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIO-key International 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Intrusion 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media prefer BKYI or INTZ?

In the previous week, BIO-key International had 3 more articles in the media than Intrusion. MarketBeat recorded 11 mentions for BIO-key International and 8 mentions for Intrusion. BIO-key International's average media sentiment score of 0.39 beat Intrusion's score of -0.01 indicating that BIO-key International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BIO-key International 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Intrusion 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend AUID or BKYI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score authID 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 BIO-key International 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to AUID or BKYI?

In the previous week, BIO-key International had 9 more articles in the media than authID. MarketBeat recorded 11 mentions for BIO-key International and 2 mentions for authID. authID's average media sentiment score of 0.94 beat BIO-key International's score of 0.39 indicating that authID is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment authID 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BIO-key International 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend ARQQW or BKYI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arqit Quantum 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 BIO-key International 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Which has better earnings and valuation, ARQQW or BKYI?

Arqit Quantum has higher earnings, but lower revenue than BIO-key International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Arqit Quantum $1.09M N/A N/A N/A N/A BIO-key International $6.09M 0.67 -$7.16M -$5.55 N/A

Do analysts prefer BKYI or BTQ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIO-key International 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 BTQ Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable valuation & earnings, BKYI or BTQ?

BTQ Technologies has lower revenue, but higher earnings than BIO-key International. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BIO-key International $6.09M 0.67 -$7.16M -$5.55 N/A BTQ Technologies $65.50K N/A N/A N/A N/A

Does the media prefer BKYI or BTQ?

In the previous week, BIO-key International had 1 more articles in the media than BTQ Technologies. MarketBeat recorded 11 mentions for BIO-key International and 10 mentions for BTQ Technologies. BTQ Technologies' average media sentiment score of 0.42 beat BIO-key International's score of 0.39 indicating that BTQ Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BIO-key International 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BTQ Technologies 0 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate BKYI or MSFT?

Microsoft has a consensus price target of $560.27, suggesting a potential upside of 12.76%. Given Microsoft's stronger consensus rating and higher probable upside, analysts plainly believe Microsoft is more favorable than BIO-key International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIO-key International 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Microsoft 0 Sell rating(s) 5 Hold rating(s) 42 Buy rating(s) 0 Strong Buy rating(s) 2.89

Does the media favor BKYI or MSFT?

In the previous week, Microsoft had 349 more articles in the media than BIO-key International. MarketBeat recorded 360 mentions for Microsoft and 11 mentions for BIO-key International. Microsoft's average media sentiment score of 1.02 beat BIO-key International's score of 0.39 indicating that Microsoft is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BIO-key International 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Microsoft 233 Very Positive mention(s) 45 Positive mention(s) 46 Neutral mention(s) 22 Negative mention(s) 9 Very Negative mention(s) Positive

BIO-key International (BKYI) Competitors

$3.77 +0.01 (+0.27%)

Closing price 04:00 PM Eastern

Extended Trading

$3.08 -0.69 (-18.22%)

As of 06:06 PM Eastern

Compare

BKYI vs. INTZ, AUID, ARQQW, BTQ, and MSFT

Should you buy BIO-key International stock or one of its competitors? BIO-key International's main competitors and comparable companies include Intrusion (INTZ), authID (AUID), Arqit Quantum (ARQQW), BTQ Technologies (BTQ), and Microsoft (MSFT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does BIO-key International compare to Intrusion?

BIO-key International (NASDAQ:BKYI) and Intrusion (NASDAQ:INTZ) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

BIO-key International has a net margin of -60.59% compared to Intrusion's net margin of -191.24%. BIO-key International's return on equity of -70.21% beat Intrusion's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIO-key International	-60.59%	-70.21%	-43.34%
Intrusion	-191.24%	-159.79%	-103.80%

BIO-key International has a beta of 0.44, meaning that its share price is 56% less volatile than the broader market. Comparatively, Intrusion has a beta of -1.57, meaning that its share price is 257% less volatile than the broader market.

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 19.4% of Intrusion shares are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Comparatively, 10.1% of Intrusion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Intrusion has a consensus price target of $5.25, suggesting a potential upside of 683.58%. Given Intrusion's stronger consensus rating and higher probable upside, analysts plainly believe Intrusion is more favorable than BIO-key International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Intrusion	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

BIO-key International has higher earnings, but lower revenue than Intrusion. Intrusion is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.09M	0.67	-$7.16M	-$5.55	N/A
Intrusion	$7.09M	2.32	-$9.06M	-$0.52	N/A

In the previous week, BIO-key International had 3 more articles in the media than Intrusion. MarketBeat recorded 11 mentions for BIO-key International and 8 mentions for Intrusion. BIO-key International's average media sentiment score of 0.39 beat Intrusion's score of -0.01 indicating that BIO-key International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BIO-key International	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Intrusion	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

BIO-key International beats Intrusion on 9 of the 16 factors compared between the two stocks.

How does BIO-key International compare to authID?

authID (NASDAQ:AUID) and BIO-key International (NASDAQ:BKYI) are both small-cap technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

BIO-key International has a net margin of -60.59% compared to authID's net margin of -616.91%. BIO-key International's return on equity of -70.21% beat authID's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
authID	-616.91%	-202.14%	-168.10%
BIO-key International	-60.59%	-70.21%	-43.34%

8.8% of authID shares are owned by institutional investors. Comparatively, 26.5% of BIO-key International shares are owned by institutional investors. 17.4% of authID shares are owned by insiders. Comparatively, 4.0% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

authID has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market. Comparatively, BIO-key International has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market.

BIO-key International has higher revenue and earnings than authID. BIO-key International is trading at a lower price-to-earnings ratio than authID, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
authID	$2.04M	3.88	-$17.93M	-$1.27	N/A
BIO-key International	$6.09M	0.67	-$7.16M	-$5.55	N/A

In the previous week, BIO-key International had 9 more articles in the media than authID. MarketBeat recorded 11 mentions for BIO-key International and 2 mentions for authID. authID's average media sentiment score of 0.94 beat BIO-key International's score of 0.39 indicating that authID is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
authID	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BIO-key International	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
authID	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BIO-key International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

BIO-key International beats authID on 8 of the 14 factors compared between the two stocks.

How does BIO-key International compare to Arqit Quantum?

Arqit Quantum (NASDAQ:ARQQW) and BIO-key International (NASDAQ:BKYI) are both technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Arqit Quantum	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
BIO-key International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Arqit Quantum has higher earnings, but lower revenue than BIO-key International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Arqit Quantum	$1.09M	N/A	N/A	N/A	N/A
BIO-key International	$6.09M	0.67	-$7.16M	-$5.55	N/A

In the previous week, BIO-key International had 10 more articles in the media than Arqit Quantum. MarketBeat recorded 11 mentions for BIO-key International and 1 mentions for Arqit Quantum. Arqit Quantum's average media sentiment score of 1.87 beat BIO-key International's score of 0.39 indicating that Arqit Quantum is being referred to more favorably in the media.

Company	Overall Sentiment
Arqit Quantum	Very Positive
BIO-key International	Neutral

Arqit Quantum has a net margin of 0.00% compared to BIO-key International's net margin of -60.59%. Arqit Quantum's return on equity of 0.00% beat BIO-key International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Arqit Quantum	N/A	N/A	N/A
BIO-key International	-60.59%	-70.21%	-43.34%

26.5% of BIO-key International shares are owned by institutional investors. 4.0% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

BIO-key International beats Arqit Quantum on 5 of the 9 factors compared between the two stocks.

How does BIO-key International compare to BTQ Technologies?

BIO-key International (NASDAQ:BKYI) and BTQ Technologies (NASDAQ:BTQ) are both technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
BTQ Technologies	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

BTQ Technologies has a net margin of 0.00% compared to BIO-key International's net margin of -60.59%. BTQ Technologies' return on equity of 0.00% beat BIO-key International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIO-key International	-60.59%	-70.21%	-43.34%
BTQ Technologies	N/A	N/A	N/A

26.5% of BIO-key International shares are held by institutional investors. 4.0% of BIO-key International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

BTQ Technologies has lower revenue, but higher earnings than BIO-key International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.09M	0.67	-$7.16M	-$5.55	N/A
BTQ Technologies	$65.50K	N/A	N/A	N/A	N/A

In the previous week, BIO-key International had 1 more articles in the media than BTQ Technologies. MarketBeat recorded 11 mentions for BIO-key International and 10 mentions for BTQ Technologies. BTQ Technologies' average media sentiment score of 0.42 beat BIO-key International's score of 0.39 indicating that BTQ Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BIO-key International	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BTQ Technologies	0 Very Positive mention(s)	2 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

BTQ Technologies beats BIO-key International on 6 of the 10 factors compared between the two stocks.

How does BIO-key International compare to Microsoft?

BIO-key International (NASDAQ:BKYI) and Microsoft (NASDAQ:MSFT) are both technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, dividends, risk and analyst recommendations.

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 71.1% of Microsoft shares are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Comparatively, 0.0% of Microsoft shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Microsoft has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Microsoft, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BIO-key International	$6.09M	0.67	-$7.16M	-$5.55	N/A
Microsoft	$331.84B	11.12	$133.75B	$17.96	27.67

In the previous week, Microsoft had 349 more articles in the media than BIO-key International. MarketBeat recorded 360 mentions for Microsoft and 11 mentions for BIO-key International. Microsoft's average media sentiment score of 1.02 beat BIO-key International's score of 0.39 indicating that Microsoft is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BIO-key International	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Microsoft	233 Very Positive mention(s)	45 Positive mention(s)	46 Neutral mention(s)	22 Negative mention(s)	9 Very Negative mention(s)	Positive

BIO-key International has a beta of 0.44, indicating that its stock price is 56% less volatile than the broader market. Comparatively, Microsoft has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market.

Microsoft has a consensus price target of $560.27, suggesting a potential upside of 12.76%. Given Microsoft's stronger consensus rating and higher probable upside, analysts plainly believe Microsoft is more favorable than BIO-key International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Microsoft	0 Sell rating(s)	5 Hold rating(s)	42 Buy rating(s)	0 Strong Buy rating(s)	2.89

Microsoft has a net margin of 40.31% compared to BIO-key International's net margin of -60.59%. Microsoft's return on equity of 31.98% beat BIO-key International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BIO-key International	-60.59%	-70.21%	-43.34%
Microsoft	40.31%	31.98%	18.70%

Summary

Microsoft beats BIO-key International on 15 of the 16 factors compared between the two stocks.

Get BIO-key International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BKYI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BKYI vs. The Competition

Export

Metric	BIO-key International	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$4.09M	$15.71B	$30.36B	$12.99B
Dividend Yield	N/A	3.43%	2.73%	10.61%
P/E Ratio	-0.68	128.32	75.44	25.23
Price / Sales	0.67	1,305.59	601.57	90.87
Price / Cash	N/A	47.30	52.35	50.75
Price / Book	0.80	7.19	9.65	6.24
Net Income	-$7.16M	$438.01M	$681.78M	$347.70M
7 Day Performance	-5.28%	2.47%	3.09%	1.92%
1 Month Performance	-21.52%	3.41%	3.11%	1.05%
1 Year Performance	-52.40%	8.30%	198.00%	19.53%

BIO-key International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BKYI BIO-key International	0.7919 of 5 stars	$3.77 +0.3%	N/A	-53.5%	$4.09M	$6.09M	N/A	50	News Coverage Earnings Report Upcoming Earnings Short Interest Increase
INTZ Intrusion	4.0327 of 5 stars	$0.79 +1.4%	$5.25 +568.8%	-65.4%	$17.75M	$7.09M	N/A	60	Earnings Report Short Interest Decrease
AUID authID	1.4584 of 5 stars	$0.77 -2.7%	N/A	-87.6%	$12.81M	$2.04M	N/A	60
ARQQW Arqit Quantum	N/A	$0.02 -14.4%	N/A	-96.6%	$0.00	$1.09M	N/A	147	Gap Up
BTQ BTQ Technologies	N/A	$3.95 -0.8%	N/A	+17.3%	$0.00	$65.50K	N/A	N/A	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BKYI) was last updated on 8/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BIO-key International (BKYI) Competitors

BKYI vs. INTZ, AUID, ARQQW, BTQ, and MSFT

How does BIO-key International compare to Intrusion?

Summary

How does BIO-key International compare to authID?

Summary

How does BIO-key International compare to Arqit Quantum?

Summary

How does BIO-key International compare to BTQ Technologies?

Summary

How does BIO-key International compare to Microsoft?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BKYI vs. The Competition

BIO-key International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BIO-key International (BKYI) Competitors

BKYI vs. INTZ, AUID, ARQQW, BTQ, and MSFT

How does BIO-key International compare to Intrusion?

Is BKYI or INTZ more profitable?

Which has more volatility & risk, BKYI or INTZ?

Do insiders & institutionals have more ownership in BKYI or INTZ?

Do analysts rate BKYI or INTZ?

Which has better earnings & valuation, BKYI or INTZ?

Does the media prefer BKYI or INTZ?

Summary

How does BIO-key International compare to authID?

Is AUID or BKYI more profitable?

Do insiders and institutionals believe in AUID or BKYI?

Which has more volatility and risk, AUID or BKYI?

Which has stronger earnings & valuation, AUID or BKYI?

Does the media refer more to AUID or BKYI?

Do analysts recommend AUID or BKYI?

Summary

How does BIO-key International compare to Arqit Quantum?

Do analysts recommend ARQQW or BKYI?

Which has better earnings and valuation, ARQQW or BKYI?

Does the media prefer ARQQW or BKYI?

Is ARQQW or BKYI more profitable?

Do insiders & institutionals believe in ARQQW or BKYI?

Summary

How does BIO-key International compare to BTQ Technologies?

Do analysts prefer BKYI or BTQ?

Is BKYI or BTQ more profitable?

Do institutionals and insiders have more ownership in BKYI or BTQ?

Which has preferable valuation & earnings, BKYI or BTQ?

Does the media prefer BKYI or BTQ?

Summary

How does BIO-key International compare to Microsoft?

Do institutionals & insiders have more ownership in BKYI or MSFT?

Which has better earnings and valuation, BKYI or MSFT?

Does the media favor BKYI or MSFT?

Which has more volatility & risk, BKYI or MSFT?

Do analysts rate BKYI or MSFT?

Is BKYI or MSFT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BKYI vs. The Competition

BIO-key International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools